Gordon Bethwaite of Vitranu at the Fall Startup and Venture Capital Summit in November 2021.
July 6, 2022
Ohio State Startup Feature - Vitranu
Vitranu is developing a Tunable Extended Release Capsule (TERCTM) for biologic pharmaceuticals delivered via intravitreal injection. Vitranu uses a novel electrospinning technology to produce a tiny, double walled, tunable capsule that can be filled with either biologic or small molecule therapeutics.
At the Fall Startup and Venture Capital Summit in November 2021, Gordon Bethwaite, chief executive officer shared more on Vitranu's vision to preserve the sight of every patient with treatable retinal disease.
Researchers at Ohio State disclose over 300 new inventions each year across a spectrum of sectors and applications. Startups offer a compelling, flexible path to advance innovations toward commercial adoption and success. Ohio State’s 90+ startup portfolio is growing and creatively disrupting industries such as healthcare, information technology, materials, transportation, agribusiness and more producing profound change in the way we live.
